Vivo Opportunity Fund Holdings, L.P.

13D and 13G Filings

13D/G filings: 13D on 1 security, 13G on 24 securities
CIK: 0001930214
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
ArriVent BioPharma, Inc. 13G AVBP · 04272N102	AVBP	04272N102	5.0%	2,472,701	13G	10/13/2026 Event 10/6/2026
Vivo Opportunity Fund Holdings, L.P.			3.1%	1,514,446
Vivo Opportunity Co-Invest, L.P.			0.3%	176,752
Vivo Opportunity Co-Invest (Cycle 3), L.P.			1.6%	781,503
Vivo Opportunity, LLC			5.0%	2,472,701
Vivo Opportunity Cayman Fund, L.P.			0.3%	152,971
Vivo Opportunity Cayman, LLC			0.3%	152,971
Unicycive Therapeutics, Inc. 13G/A Amendment 4 UNCY · 90466Y202	UNCY	90466Y202	10.0%	4,856,259	13G/A Amendment 4	8/14/2026 Event 6/30/2026
Vivo Opportunity Fund Holdings, L.P.			10.0%	4,856,259
Vivo Opportunity, LLC			10.0%	4,856,259
Tenax Therapeutics, Inc. 13G/A Amendment 1 TENX · 88032L605	TENX	88032L605	9.0%	3,458,327	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Vivo Opportunity Fund Holdings, L.P.			9.0%	3,458,327
Vivo Opportunity, LLC			9.0%	3,458,327
SAB Biotherapeutics, Inc. 13G/A Amendment 1 SABS · 78397T202	SABS	78397T202	10.0%	22,637,108	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Vivo Opportunity Fund Holdings, L.P.			10.0%	22,637,108
Vivo Opportunity, LLC			10.0%	22,637,108
Vivo Opportunity Cayman Fund, L.P.			10.0%	2,286,301
Vivo Opportunity Cayman, LLC			10.0%	2,286,301
Pasithea Therapeutics Corp. 13G/A Amendment 1 KTTA · 70261F202	KTTA	70261F202	10.0%	9,286,738	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Vivo Opportunity Fund Holdings, L.P.			10.0%	9,286,738
Vivo Opportunity, LLC			10.0%	9,286,738
Vivo Opportunity Cayman Fund, L.P.			10.0%	937,567
Vivo Opportunity Cayman, LLC			10.0%	937,567
Compass Therapeutics, Inc. 13G/A Amendment 1 CMPX · 20454B104	CMPX	20454B104	4.0%	7,207,573	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Vivo Opportunity Fund Holdings, L.P.			4.0%	7,207,573
Vivo Opportunity, LLC			4.0%	7,207,573
Vivo Opportunity Cayman Fund, L.P.			0.3%	549,487
Vivo Opportunity Cayman, LLC			0.3%	549,487
Clene Inc. 13G/A Amendment 3 CLNN · 185634201	CLNN	185634201	10.0%	1,321,675	13G/A Amendment 3	8/14/2026 Event 6/30/2026
Vivo Opportunity Fund Holdings, L.P.			10.0%	1,321,675
Vivo Opportunity, LLC			10.0%	1,321,675
Vivo Opportunity Cayman Fund, L.P.			10.0%	101,936
Vivo Opportunity Cayman, LLC			10.0%	101,936
Entera Bio Ltd. 13G ENTX · M40527109	ENTX	M40527109	6.9%	11,817,401	13G	8/4/2026 Event 7/28/2026
Vivo Opportunity Fund Holdings, L.P.			2.5%	4,330,882
Vivo Opportunity Co-Invest, L.P.			1.6%	2,718,137
Vivo Opportunity Co-Invest (Cycle 3), L.P.			2.8%	4,768,382
Vivo Opportunity, LLC			6.9%	11,817,401
Vivo Opportunity Cayman Fund, L.P.			0.3%	437,500
Vivo Opportunity Cayman, LLC			0.3%	437,500
Achieve Life Sciences, Inc. 13G ACHV · 004468500	ACHV	004468500	5.0%	5,305,640	13G	7/8/2026 Event 7/6/2026
Vivo Opportunity Fund Holdings, L.P.			1.8%	1,944,430
Vivo Opportunity Co-Invest, L.P.			1.2%	1,220,358
Vivo Opportunity Co-Invest (Cycle 3), L.P.			2.0%	2,140,852
Vivo Opportunity, LLC			5.0%	5,305,640
Vivo Opportunity Cayman Fund, L.P.			0.2%	196,424
Vivo Opportunity Cayman, LLC			0.2%	196,424
InMed Pharmaceuticals Inc. 13D INM · 457637700	INM	457637700	21.7%	718,444	13D	6/10/2026 Event 5/19/2026
Vivo Opportunity Fund Holdings, L.P.			21.7%	718,444
Vivo Opportunity, LLC			21.7%	718,444
Vivo Opportunity Cayman Fund, L.P.			2.2%	72,535
Vivo Opportunity Cayman, LLC			2.2%	72,535
Aclaris Therapeutics, Inc. 13G/A Amendment 1 ACRS · 00461U105	ACRS	00461U105	4.3%	5,966,370	13G/A Amendment 1	5/12/2026 Event 3/31/2026
Vivo Opportunity Fund Holdings, L.P.			4.3%	5,966,370
Vivo Opportunity, LLC			4.3%	5,966,370
Vivo Opportunity Cayman Fund, L.P.			0.5%	700,296
Vivo Opportunity Cayman, LLC			0.5%	700,296
Clene Inc. 13G/A Amendment 2 CLNN · 185634102	CLNN	185634102	10.0%	1,886,469	13G/A Amendment 2	5/12/2026 Event 3/31/2026
Vivo Opportunity Fund Holdings, L.P.			10.0%	1,886,469
Vivo Opportunity, LLC			10.0%	1,886,469
Vivo Opportunity Cayman Fund, L.P.			10.0%	127,420
Vivo Opportunity Cayman, LLC			10.0%	127,420
DBV Technologies S.A. 13G/A Amendment 2 DBVT · 23306J309	DBVT	23306J309	4.0%	11,820,005	13G/A Amendment 2	5/12/2026 Event 3/31/2026
Vivo Opportunity Fund Holdings, L.P.			4.0%	11,820,005
Vivo Opportunity, LLC			4.0%	11,820,005
Vivo Opportunity Cayman Fund, L.P.			0.5%	1,517,840
Vivo Opportunity Cayman, LLC			0.5%	1,517,840
Bright Minds Biosciences Inc. 13G/A Amendment 1 DRUG · 10919W405	DRUG	10919W405	5.2%	504,645	13G/A Amendment 1	5/12/2026 Event 3/31/2026
Vivo Opportunity Fund Holdings, L.P.			5.2%	504,645
Vivo Opportunity, LLC			5.2%	504,645
Vivo Opportunity Cayman Fund, L.P.			0.5%	52,527
Vivo Opportunity Cayman, LLC			0.5%	52,527
AN2 Therapeutics, Inc. 13G ANTX · 037326105	ANTX	037326105	8.0%	2,864,346	13G	3/13/2026 Event 3/10/2026
Vivo Opportunity Fund Holdings, L.P.			8.0%	2,864,346
Vivo Opportunity, LLC			8.0%	2,864,346
Vivo Opportunity Cayman Fund, L.P.			0.8%	289,294
Vivo Opportunity Cayman, LLC			0.8%	289,294
Immunic, Inc. 13G IMUX · 4525EP101	IMUX	4525EP101	10.0%	29,126,906	13G	2/20/2026 Event 2/17/2026
Vivo Opportunity Fund Holdings, L.P.			10.0%	29,126,906
Vivo Opportunity, LLC			10.0%	29,126,906
Vivo Opportunity Cayman Fund, L.P.			10.0%	2,942,094
Vivo Opportunity Cayman, LLC			10.0%	2,942,094
Terns Pharmaceuticals, Inc. 13G/A Amendment 3 TERN · 880881107	TERN	880881107	2.5%	2,700,615	13G/A Amendment 3	2/13/2026 Event 1/31/2025
Vivo Capital Fund VIII, L.P.			0.9%	966,461
Vivo Capital Surplus Fund VIII, L.P.			0.1%	133,415
Vivo Capital VIII, LLC			1.0%	1,099,876
Vivo Opportunity Fund Holdings, L.P.			2.5%	2,700,615
Vivo Opportunity, LLC			2.5%	2,700,615
Vivo Opportunity Cayman Fund, L.P.			0.2%	241,652
Vivo Opportunity Cayman, LLC			0.2%	241,652
DBV Technologies S.A. 13G/A Amendment 1 DBVT · 23306J309	DBVT	23306J309	5.7%	15,685,950	13G/A Amendment 1	2/13/2026 Event 1/12/2026
Vivo Opportunity Fund Holdings, L.P.			5.7%	15,685,950
Vivo Opportunity, LLC			5.7%	15,685,950
Vivo Opportunity Cayman Fund, L.P.			0.7%	2,014,280
Vivo Opportunity Cayman, LLC			0.7%	2,014,280
Cidara Therapeutics, Inc. 13G/A Amendment 3 CDTX · 171757206	CDTX	171757206	0%	0	13G/A Amendment 3	2/13/2026 Event 1/7/2026
Vivo Opportunity Fund Holdings, L.P.			0%	0
Vivo Opportunity, LLC			0%	0
Vivo Opportunity Cayman Fund, L.P.			0%	0
Vivo Opportunity Cayman, LLC			0%	0
Camp4 Therapeutics Corp 13G/A Amendment 1 CAMP · 13463J101	CAMP	13463J101	7.4%	3,856,991	13G/A Amendment 1	2/13/2026 Event 12/31/2025
Vivo Opportunity Fund Holdings, L.P.			7.4%	3,856,991
Vivo Opportunity, LLC			7.4%	3,856,991
Vivo Opportunity Cayman Fund, L.P.			0.8%	389,577
Vivo Opportunity Cayman, LLC			0.8%	389,577
Minerva Neurosciences, Inc. 13G NERV · 603380205	NERV	603380205	10.0%	8,591,572	13G	12/31/2025 Event 12/23/2025
Vivo Opportunity Fund Holdings, L.P.			10.0%	8,591,572
Vivo Opportunity, LLC			10.0%	8,591,572
Vivo Opportunity Cayman Fund, L.P.			10.0%	868,428
Vivo Opportunity Cayman, LLC			10.0%	868,428
Pasithea Therapeutics Corp. 13G KTTA · 70261F202	KTTA	70261F202	10.0%	17,560,467	13G	12/5/2025 Event 12/1/2025
Vivo Opportunity Fund Holdings, L.P.			10.0%	17,560,467
Vivo Opportunity, LLC			10.0%	17,560,467
Vivo Opportunity Cayman Fund, L.P.			10.0%	1,772,867
Vivo Opportunity Cayman, LLC			10.0%	1,772,867
Bright Minds Biosciences Inc. 13G DRUG · 10919W405	DRUG	10919W405	6.4%	454,184	13G	11/14/2025 Event 9/30/2025
Vivo Opportunity Fund Holdings, L.P.			6.4%	454,184
Vivo Opportunity, LLC			6.4%	454,184
Vivo Opportunity Cayman Fund, L.P.			0.7%	47,433
Vivo Opportunity Cayman, LLC			0.7%	47,433
COMPASS Pathways plc 13G/A Amendment 2 CMPS · 20451W101	CMPS	20451W101	3.2%	3,174,494	13G/A Amendment 2	11/14/2025 Event 9/30/2025
Vivo Opportunity Fund Holdings, L.P.			3.2%	3,174,494
Vivo Opportunity, LLC			3.2%	3,174,494
Vivo Opportunity Cayman Fund, L.P.			0.2%	187,891
Vivo Opportunity Cayman, LLC			0.2%	187,891
Compass Therapeutics, Inc. 13G CMPX · 20454B104	CMPX	20454B104	5.1%	8,995,979	13G	11/14/2025 Event 9/30/2025
Vivo Opportunity Fund Holdings, L.P.			5.1%	8,995,979
Vivo Opportunity, LLC			5.1%	8,995,979
Vivo Opportunity Cayman Fund, L.P.			0.3%	549,487
Vivo Opportunity Cayman, LLC			0.3%	549,487
Soleno Therapeutics, Inc. 13G/A Amendment 3 SLNO · 834203309	SLNO	834203309	4.2%	2,251,160	13G/A Amendment 3	11/14/2025 Event 9/30/2025
Vivo Opportunity Fund Holdings, L.P.			4.2%	2,251,160
Vivo Opportunity, LLC			4.2%	2,251,160
Vivo Opportunity Cayman Fund, L.P.			0.1%	27,043
Vivo Opportunity Cayman, LLC			0.1%	27,043
Unicycive Therapeutics, Inc. 13G/A Amendment 3 UNCY · 90466Y202	UNCY	90466Y202	10.0%	6,096,175	13G/A Amendment 3	11/14/2025 Event 9/30/2025
Vivo Opportunity Fund Holdings, L.P.			10.0%	6,096,175
Vivo Opportunity, LLC			10.0%	6,096,175
SAB Biotherapeutics, Inc. 13G SABS · 78397T202	SABS	78397T202	10.0%	25,931,000	13G	10/3/2025 Event 9/29/2025
Vivo Opportunity Fund Holdings, L.P.			10.0%	25,931,000
Vivo Opportunity, LLC			10.0%	25,931,000
Vivo Opportunity Cayman Fund, L.P.			10.0%	2,619,000
Vivo Opportunity Cayman, LLC			10.0%	2,619,000
Camp4 Therapeutics Corp 13G CAMP · 13463J101	CAMP	13463J101	7.6%	3,561,793	13G	9/17/2025 Event 9/11/2025
Vivo Opportunity Fund Holdings, L.P.			7.6%	3,561,793
Vivo Opportunity, LLC			7.6%	3,561,793
Vivo Opportunity Cayman Fund, L.P.			0.8%	359,775
Vivo Opportunity Cayman, LLC			0.8%	359,775
Soleno Therapeutics, Inc. 13G/A Amendment 2 SLNO · 834203309	SLNO	834203309	7.4%	3,958,294	13G/A Amendment 2	8/12/2025 Event 6/30/2025
Vivo Opportunity Fund Holdings, L.P.			7.4%	3,958,294
Vivo Opportunity, LLC			7.4%	3,958,294
Cidara Therapeutics, Inc. 13G/A Amendment 2 CDTX · 171757206	CDTX	171757206	4.6%	1,175,796	13G/A Amendment 2	8/12/2025 Event 6/30/2025
Vivo Opportunity Fund Holdings, L.P.			4.6%	1,175,796
Vivo Opportunity, LLC			4.6%	1,175,796
Vivo Opportunity Cayman Fund, L.P.			0.5%	135,629
Vivo Opportunity Cayman, LLC			0.5%	135,629
Regulus Therapeutics Inc. 13G/A Amendment 1 RGLS · 75915K309	RGLS	75915K309	3.9%	2,696,426	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Vivo Opportunity Fund Holdings, L.P.			3.9%	2,696,426
Vivo Opportunity, LLC			3.9%	2,696,426
Delcath Systems, Inc. 13G/A Amendment 2 DCTH · 24661P807	DCTH	24661P807	2.2%	750,195	13G/A Amendment 2	5/15/2025 Event 3/31/2025
Vivo Opportunity Fund Holdings, L.P.			2.2%	750,195
Vivo Opportunity, LLC			2.2%	750,195
COMPASS Pathways plc 13G/A Amendment 1 CMPS · 20451W101	CMPS	20451W101	6.6%	6,348,988	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Vivo Opportunity Fund Holdings, L.P.			6.6%	6,348,988
Vivo Opportunity, LLC			6.6%	6,348,988
Vivo Opportunity Cayman Fund, L.P.			0.4%	375,782
Vivo Opportunity Cayman, LLC			0.4%	375,782
Cidara Therapeutics, Inc. 13G/A Amendment 1 CDTX · 171757206	CDTX	171757206	4.7%	612,276	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Vivo Opportunity Fund Holdings, L.P.			4.7%	612,276
Vivo Opportunity, LLC			4.7%	612,276
Vivo Opportunity Cayman Fund, L.P.			0.6%	72,000
Vivo Opportunity Cayman, LLC			0.6%	72,000
Unicycive Therapeutics, Inc. 13G/A Amendment 2 UNCY · 90466Y103	UNCY	90466Y103	10.0%	60,961,729	13G/A Amendment 2	5/15/2025 Event 3/31/2025
Vivo Opportunity Fund Holdings, L.P.			10.0%	60,961,729
Vivo Opportunity, LLC			10.0%	60,961,729
DBV Technologies S.A. 13G DBVT · 23306J309	DBVT	23306J309	10.0%	20,358,470	13G	4/8/2025 Event 4/7/2025
Vivo Opportunity Fund Holdings, L.P.			10.0%	20,358,470
Vivo Opportunity, LLC			10.0%	20,358,470
Vivo Opportunity Cayman Fund, L.P.			10.0%	2,614,293
Vivo Opportunity Cayman, LLC			10.0%	2,614,293
Soleno Therapeutics, Inc. 13G/A Amendment 1 SLNO · 834203309	SLNO	834203309	9.7%	4,458,294	13G/A Amendment 1	3/31/2025 Event 3/31/2025
Vivo Opportunity Fund Holdings, L.P.			9.7%	4,458,294
Vivo Opportunity, LLC			9.7%	4,458,294

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.